Trial Profile

A clinical trial assessing neuropsychotherapeutics in alcohol use disorder

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 20 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EPV 001 (Primary)
Indications Alcoholism
Focus Adverse reactions

Most Recent Events

20 Sep 2022 New trial record
13 Sep 2022 According to EpiVario, Inc., media release, company to receive over $250,000 in research funding, this funding will advance the preclinical research and aspire to begin this human trial by the first half of 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com